Healthcare Triangle Faces Nasdaq Delisting Notice

TL;DR

Nasdaq is threatening to delist HTRI, stock might tank.

AI Summary

Healthcare Triangle, Inc. has received a notice of delisting or failure to satisfy a continued listing rule or standard from the Nasdaq Stock Market LLC. The company was notified on January 14, 2025, that it is not in compliance with certain listing requirements. This filing serves as a current report regarding this critical development.

Why It Matters

This notice indicates potential delisting from Nasdaq, which could significantly impact the company's stock liquidity and investor confidence.

Risk Assessment

Risk Level: high — A delisting notice from a major exchange like Nasdaq poses a significant risk to the company's market presence and stock value.

Key Players & Entities

• Healthcare Triangle, Inc. (company) — Registrant
• Nasdaq Stock Market LLC (company) — Listing Exchange
• January 14, 2025 (date) — Date of Notification

FAQ

Key Financial Figures

• $0.00001 — ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar

Filing Documents

• ea0228086-8k_healthcare.htm (8-K) — 28KB
• 0001213900-25-005057.txt ( ) — 200KB
• hcti-20250114.xsd (EX-101.SCH) — 3KB
• hcti-20250114_lab.xml (EX-101.LAB) — 33KB
• hcti-20250114_pre.xml (EX-101.PRE) — 22KB
• ea0228086-8k_healthcare_htm.xml (XML) — 4KB

01 Notice of Delisting or Failure to Satisfy a Continued

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, was granted a continued listing exception by the Nasdaq Hearings Panel (the " Panel ") to allow the Company to complete its plan to demonstrate compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Stock Market LLC (" Nasdaq "). of the date of this Current Report on Form 8-K. On January 14, 2025, Healthcare Triangle, Inc. (the " Company "), received a letter from Nasdaq ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rules since it has not yet held an annual meeting of shareholders within twelve months of the Company's fiscal year end and since the Nasdaq Hearings panel is currently considering the Company's continued listing on based on another compliance matter, the Panel will include the Company's annual meeting non-compliance as an additional basis for delisting. No annual meeting of stockholders was held in 2024 due primarily to the delay in the completion and filing of its Annual Report on Form 10-K because of the dismissal of its prior auditor, BF Borgers CPA PC, as a result of a settlement by BF Borgers of charges made by the Securities and Exchange Commission. The Company is currently planning for its 2024 Annual Meeting of Stockholders to be held by March 31, 2025 and will provide stockholders of record with proxy materials in advance of the Meeting. The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market. There can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will evidence compliance within any extension period that may be granted by the Panel.

Forward Looking Statements

Forward Looking Statements This Current Report contains forward-looking statements that involve risks and uncertainties intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of current or historical fact contained in this Current Report, including statements regarding the Company's expected timeline for compliance with the Nasdaq's Corporate Governance Rules, are forward-looking statements. The words "anticipate," "believe," "continue," "should," "estimate," "expect," "intend," "may," "plan," "project," "will," and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. The Company has based these forward-looking statements on the current expectations about future events held by management. While the Company believes these expectations are reasonable, such forward-looking statements are inherently subject to risks and uncertainties, many of which are beyond the Company's control. The Company's actual future results may differ materially from those discussed here for various reasons. Given these uncertainties, you should not place undue reliance on these forward-looking statements. The forward-looking statements included in this Current Report are made only as of the date hereof. We do not undertake any obligation to update any such statements or to publicly announce the results of any revisions to any of such statements to reflect future events or developments. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Healthcare Triangle, Inc. Date: January 21, 2025 By: /s/ Thyagarajan Ramachandran Name: Thyagarajan Ramachandran Title: Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR